Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are advancing a pipeline of first-in-class tailored antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders, and a highly experienced leadership team, Mestag offers an exciting, diverse, and balanced place to work, with competitive benefits, generous vacation time, and the room to grow and develop your career.